Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection (clinicaltrials.gov) - Jul 27, 2023 - P3 | N=250 | Completed | Sponsor: Valenta Pharm JSC | Recruiting ➔ Completed | Trial completion date: Dec 2023 ➔ Jul 2022
Trial completion • Trial completion date • Cough • Infectious Disease • Influenza • Respiratory Diseases
|